Allergan and the Saint Regis Mohawk Tribe suffered a blow today as the US Court of Appeals for the Federal Circuit affirmed a decision rejecting use of tribal sovereign immunity in the inter partes review.
Greenberg Traurig announced on Monday, July 16, that it has added Brian Rubenstein as a shareholder in its Philadelphia office.
Novartis has signed a global licensing agreement with two biotechnology companies centring on the development of an antibody treatment for inflammatory skin conditions.
Sanofi has partnered with biotechnology company Revolution Medicines to develop treatments for multiple cancers.
Ropes & Gray has added Charlotte Jacobsen from Fitzpatrick, Cella, Harper & Scinto as a partner in the firm’s life sciences IP litigation practice.
US-based law firm Cantor Colburn has hired Bryan Zerhusen as a partner and chair of the firm’s life sciences practice group.
The US Food and Drug Administration is not going to play regulatory ‘whack-a-mole’ with companies trying to delay or derail the entry of biosimilar competitors, according to Scott Gottlieb, commissioner of the FDA.
US-based biopharmaceutical company AbbVie entered into a patent licensing agreement with generics company Mylan yesterday.
A CRISPR patent owned by the Broad Institute of Harvard and MIT is “unpatentable for indefiniteness”, according to an agriculture biotech company.
The US Court of Appeals for the Federal Circuit has rejected Jazz Pharmaceuticals’ attempt to revive patents covering its narcolepsy drug Xyrem.